Lilly ships Trulicity to pharmacies
Eli Lilly and Co. has released Trulicity, a once-weekly treatment for type 2 diabetes, to U.S. pharmacies. Lilly said Monday that Trulicity (dulaglutide) comes in a single-dose pen, in 0.75 mg and 1.5 mg doses, and doesn’t require patients to mix, measure, or handle the needle.